EPISODIC TRANSDERMAL DELIVERY FROM MELTABLE VEHICLES

Information

  • Research Project
  • 2790174
  • ApplicationId
    2790174
  • Core Project Number
    R43AR045145
  • Full Project Number
    1R43AR045145-01A1
  • Serial Number
    45145
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/1999 - 25 years ago
  • Project End Date
    2/29/2000 - 24 years ago
  • Program Officer Name
    MOSHELL, ALAN N.
  • Budget Start Date
    3/1/1999 - 25 years ago
  • Budget End Date
    2/29/2000 - 24 years ago
  • Fiscal Year
    1999
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    2/24/1999 - 26 years ago
Organizations

EPISODIC TRANSDERMAL DELIVERY FROM MELTABLE VEHICLES

DESCRIPTION (Adapted from the application): The aim of this project is to demonstrate episodic delivery from a transdermal patch. In the proposed approach, a meltable transdermal vehicle will be warmed by a small aerobic heat source similar to those used in pocket warmers. Heat generation and the resulting drug delivery can be turned on and off by controlling the availability of air to the heat source, initially by hand, and potentially by a small programmed controller. Nicotine will be used as the demonstration drug because an episodic nicotine patch would be useful for smoking therapy and might facilitate other medical applications of nicotine. BIOTEK has shown that delivery of nicotine from a meltable formulation can be repeatedly increased and decreased by adjusting the temperature just above or below the melting point of the delivery medium. Other experiments have shown that small aerobic heat generators can be turned off and on for many hours while in place on the skin. Phase I will expand this work to show that thermoregulated transdermal delivery can be reproducibly achieved and controlled in both in vitro and in vivo; Phase II will then develop the practical commercial patch design and conduct a Phase I human clinical study of the final design. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R43
  • Administering IC
    AR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG3
  • Study Section Name
  • Organization Name
    BIOTEK, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    WOBURN
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01801
  • Organization District
    UNITED STATES